DSM has transfered the Teavigo brand Epigallocatechin gallate (EGCG) business to Taiyo Kagaku, under a licensing deal, on July 1, 2014.
Under terms of the deal, Taiyo will become the sole producer of Teavigo by the end of 2014.
Teavigo brand EGCG had previously been distributed under license by Pharmachem Laboratories, Inc. in the dietary supplement segment and by DSM in the food and beverage segments.
Under terms of the agreement, Taiyo will take responsibility for all customer segments, globally.
During the transitional period, DSM, Pharmachem and Taiyo, will collectively work together to allow for an orderly transition for their customers and are dedicated to assure an uninterrupted supply of the ingredient.